contract_awardAwarded Monday, August 24, 2026Analyzed

BAXTER HEALTHCARE CORPORATION: $18.8M Department of Health and Human Services Contract

Neutral

Summary

This $18.8M contract to Baxter Healthcare Corporation for sodium chloride IV solution bags supports the Department of Health and Human Services' preparedness efforts. Since Baxter Healthcare Corporation is a private entity, no publicly traded company is directly tied to this award.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.The contract is for a routine medical supply (sodium chloride IV bags) and is not linked to any public company.
  • 2.The award amount is relatively small at $18.8M over two years, limiting its market impact.
  • 3.Investors should monitor future awards from the Office of Assistant Secretary for Preparedness and Response for potential ties to public healthcare companies.

Market Implications

This contract has no direct implications for publicly traded stocks due to the private nature of the recipient. The broader healthcare sector may see indirect benefits from sustained government investment in medical countermeasures and hospital readiness, but no specific tickers are impacted.

Full Analysis

The Department of Health and Human Services, through the Office of Assistant Secretary for Preparedness and Response, awarded an $18.8M definitive contract to Baxter Healthcare Corporation for sodium chloride (NaCl) 0.9% for injection, 100ml solution flexi-bags. This contract spans from September 2025 to August 2027, indicating a multi-year supply agreement for a critical medical supply used in hospitals and emergency settings. Baxter Healthcare Corporation is not a publicly traded entity, and no direct parent company or subsidiary relationship to a public company is identifiable from available data. Therefore, this contract cannot be attributed to any specific ticker. The award supports the healthcare sector's medical supply chain, particularly for IV fluids, which are essential in patient care and emergency preparedness. Related bill signals, such as S5316 (BINSA Act) and HR6583 (VA Research Reform Act of 2025), touch on healthcare and technology but do not directly fund or authorize this specific contract. The contract's size is modest relative to the broader IV solutions market, and no historical pattern of stock movement for private entities is applicable. Supply chain beneficiaries, such as raw material suppliers or logistics providers, are not identifiable without further detail on Baxter's subcontractors.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Exec OrderAug 6, 2026

Continuing to Protect the Meaning and Value of American Citizenship

This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.

Exec OrderAug 6, 2026

Ending Birth Tourism

This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.

Contract Details

Recipient

BAXTER HEALTHCARE CORPORATION

Award Amount

$18,828,019

Awarding Agency

Department of Health and Human Services

Sub-Agency

Office of Assistant Secretary for Preparedness and Response

Contract Type

DEFINITIVE CONTRACT

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →